Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Northview LifeSciences

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 13
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 8
Rounds per year 1.30
Lead investments 0
Exits 5
Key employees 2

Areas of investment

  • Biotechnology
  • Medical
  • Health Care
  • Medical Device
  • Pharmaceutical
Summary

The main department of described VC is located in the Vancouver. The fund was located in North America if to be more exact in Canada.

The high activity for fund was in 2015. The fund is generally included in less than 2 deals every year. The typical startup value when the investment from Northview LifeSciences is more than 1 billion dollars. Deals in the range of 50 - 100 millions dollars are the general things for fund.

Among the most successful fund investment fields, there are Biotechnology, Medical Device. Among the various public portfolio startups of the fund, we may underline CureVac, Perimeter Medical Imaging Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Germany.

We also calculated 2 valuable employees in our database.

The standard case for the fund is to invest in rounds with 6 partakers. Despite the Northview LifeSciences, startups are often financed by dievini Hopp Biotech Holding, Bill & Melinda Gates Foundation. The meaningful sponsors for the fund in investment in the same round are dievini Hopp Biotech Holding, Sigma Group, Roadmap Capital. In the next rounds fund is usually obtained by Landeskreditbank Baden-Wu00fcrttemberg, LBBW Asset Management, Baden-Wu00fcrttembergische Versorgungsanstalt fu00fcr u00c4rzte.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Northview LifeSciences:
Typical Co-investors
Northview LifeSciences is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Northview LifeSciences:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Abstraction Capital Kansas City, Missouri, United States
Ademe -
Angel Dough Ventures Hicksville, New York, United States
Atento Capital Oklahoma, Tulsa, United States
Chloe Capital Ithaca, New York, United States
Convergys Cincinnati, Ohio, United States
Crosslantic Capital Bochum, Germany, Nordrhein-Westfalen
F3 Ventures New York, New York, United States
Giant Network China, Shanghai
ICE71 Central, Central Region, Singapore
IDB Group Israel, Tel Aviv, Tel Aviv District
KWE Beteiligungen -
LGF California, United States, West Hollywood
OnMobile Bangalore, India, Karnataka
Robert W. Woodruff Foundation Atlanta, Georgia, United States
Sage Technology Ventures California, Fremont, United States
Swarraton Partners England, London, United Kingdom
Tranquility Capital Lidköping, Sweden, Vastra Gotaland
XPV Water Partners Canada, Ontario, Toronto
z9 Capital Boca Raton, Florida, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Total Flow Medical

Manufacturing
Medical Device
06 May 2022 Vancouver, British Columbia, Canada

Abdera Therapeutics

Biotechnology
Health Care
Health Diagnostics
Life Science
01 Jan 2022 Vancouver, British Columbia, Canada

Precision NanoSystem

Biotechnology
Genetics
Health Care
Pharmaceutical
$13M29 Sep 2015 Vancouver, British Columbia

Perimeter Medical Imaging

Health Care
Medical
Medical Device
$5M22 Jul 2015 Old Toronto, Ontario, Canada

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Northview LifeSciences?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 13
Average round size 10M
Rounds per year 1.30
Peak activity year 2015
Lead investments 0
Exits 5
Group Appearance index 0.31

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Total Flow Medical

Manufacturing
Medical Device
06 May 2022 Vancouver, British Columbia, Canada

Abdera Therapeutics

Biotechnology
Health Care
Health Diagnostics
Life Science
01 Jan 2022 Vancouver, British Columbia, Canada

Precision NanoSystem

Biotechnology
Genetics
Health Care
Pharmaceutical
$13M29 Sep 2015 Vancouver, British Columbia

Perimeter Medical Imaging

Health Care
Medical
Medical Device
$5M22 Jul 2015 Old Toronto, Ontario, Canada
Crunchbase icon

Content report

The following text will be sent to our editors: